Efficacy and Safety of an Inactivated Whole-Virion SARS-CoV-2 Vaccine
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The Lancet
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Efficacy and Safety of an Inactivated Whole-Virion SARS-CoV-2 Vaccine (CoronaVac): Interim Results of a Double-Blind, Randomised, Placebo-Controlled, Phase 3 Trial in Turkey
Lancet 2021 Jul 17;398(10296)213-222, MD Tanriover, HL Doğanay, M Akova, HR Güner, A Azap, S Akhan, Ş Köse, FŞ Erdinç, EH Akalın, ÖF Tabak, H Pullukçu, Ö Batum, S Şimşek Yavuz, Ö Turhan, MT Yıldırmak, İ Köksal, Y Taşova, V Korten, G Yılmaz, MK Çelen, S Altın, İ Çelik, Y Bayındır, İ Karaoğlan, A Yılmaz, A Özkul, H Gür, S UnalFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.